TSC2 and epilepsy: A patient with TSC due to a previously unreported deletion of exons 4-8 in TSC2, ASM-resistant epilepsy who responded favorably to phenytoin (PHT) and in whom everolimus led to regression of multifocal epilepsy, to the best of our knowledge, has not been previously reported.